Atlas Trials

A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis

Clinical trial NCT06443502 · RECRUITING

Trial details

NCT number
NCT06443502
Sponsor
Takeda
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Pouchitis
Start date
2024-11-19
Primary completion
2030-01-31
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.